Raphael Pharmaceutical RAPH
OTC RAPH
$1.51 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Raphael Pharmaceutical (RAPH) Capital Expenditures (2024)

Updated

Raphael Pharmaceutical (RAPH) posted Capital Expenditures of $1,000 for Q1 2024.

Analysis

Raphael Pharmaceutical (RAPH) Capital Expenditures (2024) Analysis & Trends

For FY2022, Raphael Pharmaceutical's Capital Expenditures came in at $2,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 1.36 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 301.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 237.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 573.00 Mn
10 Raphael Pharmaceutical 30.47 Mn 30.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 1,000.00
API Access

Raphael Pharmaceutical Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RAPH&period=max&api_key=YOUR_API_KEY